E-mail:koho*office.hiroshima-u.ac.jp (Please replace*with@)
Researchers shared their expertise related to COVID-19 in Hiroshima University's first press seminar.
Hiroshima University researchers shared their expertise related to COVID-19 during the university's first press seminar on April 28.
In the same month last year, HU joined the global fight against the pandemic through the Hiroshima University CoV-Peace-Project. Laboratories in the healthcare fields at HU continue to engage in research on diagnosis, drug discovery, and other countermeasures against the virus.
READ: New treatments and promising tech vs COVID-19 emerge from HU’s laboratories
The laboratories are also working together to develop preventive vaccines and therapeutic agents against COVID-19, conducting epidemiological surveys to understand the infection situation and carrying out genome analysis.
At the press seminar, six HU researchers explained their areas of expertise and engaged in a lively exchange of opinions with reporters. During the conference, Professor Junko Tanaka — HU's Executive Vice President — commented, "Hiroshima University is responding to the research on the novel coronavirus with various studies. We ask for your continued support and assistance in the future.”
During the Q&A session
Prof. Tanaka explaining the "COVID-19 Research System at Hiroshima University"
- Profile of Executive and Vice President Junko Tanaka
- Profile of Professor Takemasa Sakaguchi
- Profile of Professor Hiroki Ohge
- Profile of Professor Hidetoshi Tahara
- Profile of Professor Hideki Ohdan
- Profile of Professor Tatsuhiko Kubo
Hiroshima University, Public Relations Group